Mounting Challenges for Simulations Plus as Legal and Financial Pressures Intensify

The biosimulation company Simulations Plus finds itself navigating the most turbulent period in its recent history. A combination of legal scrutiny, disappointing financial performance, and potential removal from a major stock index has created a perfect storm for the once-promising firm.

Financial Performance Triggers Market Reaction

The current difficulties began with a series of disappointing financial announcements. On June 11, 2025, preliminary third-quarter results fell short of market expectations, triggering an immediate 24% decline in share value. When the company released its final report on July 14, the situation worsened considerably. Despite recording modest revenue growth, Simulations Plus significantly missed consensus estimates, leading to another dramatic selloff that erased 25.75% of the company’s market value.

Legal Investigations Compound Problems

Within weeks of the financial disclosures, Simulations Plus faced legal challenges from two separate law firms. Both Rosen Law Firm and Johnson Fistel announced investigations into potential securities violations on September 11 and 12, 2025, respectively. The firms are examining whether the company may have misled investors with materially inaccurate business information. For shareholders who have already suffered substantial losses, these investigations could represent the first step toward seeking financial recovery.

Accounting Issues and Auditor Dispute Emerge

Further complicating matters, the July 14 disclosure also revealed a one-time non-cash impairment charge of $77.2 million related to previous acquisitions, including the purchase of Pro-ficiency Holdings. These acquisitions were originally intended to accelerate corporate growth.

Should investors sell immediately? Or is it worth buying Simulations Plus?

In a related development that raised additional concerns, Simulations Plus had dismissed its auditing firm, Grant Thornton, just days before the impairment announcement. The accounting firm publicly contradicted the company’s characterization of the dismissal, citing unresolved issues with segment reporting and internal controls. This revelation prompted another sharp decline of nearly 26% in the stock’s value.

Index Exclusion Looms

Adding to the company’s challenges, Simulations Plus will be removed from the S&P SmallCap 600 index effective September 22, 2025. This exclusion is expected to force index funds to liquidate their positions in the company, creating additional downward pressure on the stock price.

Despite these significant headwinds, market analysts have maintained moderately positive ratings on the company. The central question remains whether strategic adjustments implemented by CEO Shawn O’Connor and the ongoing integration of the Proficiency acquisition will be sufficient to stabilize the company’s trajectory.